{"id":972310,"date":"2026-06-15T16:34:45","date_gmt":"2026-06-15T20:34:45","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\/"},"modified":"2026-06-15T16:34:45","modified_gmt":"2026-06-15T20:34:45","slug":"park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\/","title":{"rendered":"Park Ha Biological Technology Co., Ltd. Announces Closing of $2.0 Million Registered Direct Offering"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">Wuxi, China, June  15, 2026  (GLOBE NEWSWIRE) &#8212;  Park Ha Biological Technology Co., Ltd., (NASDAQ: BYAH) an exempted company with limited liability incorporated under the laws of the Cayman Islands (the \u201cCompany\u201d), today announced the closing of its previously announced registered direct offering with several investors for the sale and purchase of an aggregate of up to 1,133,332 of the Company\u2019s Class A ordinary shares, par value $0.001 each (the \u201cClass A Ordinary Shares\u201d), and pre-funded warrants (the \u201cPre-Funded Warrants\u201d) to purchase up to 200,000 Class A Ordinary Shares, at a combined purchase price of $1.50 per Class A Ordinary Share and Pre-Funded Warrant.<\/p>\n<p align=\"justify\">The gross proceeds to the Company from the registered direct offering are estimated to be approximately $2.0 million, before deducting the placement agent\u2019s fees and other estimated offering expenses.<\/p>\n<p align=\"justify\">D. Boral Capital LLC acted as the sole placement agent for the offering. Concord &amp; Sage PC acted as counsel to the Company. Hunter Taubman Fischer &amp; Li LLC acted as US securities counsel to the placement agent.<\/p>\n<p align=\"justify\">The Company intends to use the net proceeds from this offering for general corporate and working capital purposes.<\/p>\n<p align=\"justify\">The offering of the securities described above were offered by the Company pursuant to an effective \u201cshelf\u201d registration statement on Form F-3 (File No. 333-295090) filed by the Company with the U.S. Securities and Exchange Commission (\u201cSEC\u201d) and declared effective by the SEC on June 8, 2026, and the accompanying prospectus contained therein.<\/p>\n<p align=\"justify\">The offering was made only by means of a prospectus supplement and accompanying prospectus. The prospectus supplement describing the terms of the public offering was filed with the SEC. Copies of the prospectus supplement and the accompanying prospectus relating to this offering may be obtained on the SEC\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qgRIfJlEQRhOGMxJOvC6_4l8XMNCMAqgg_fe8PqpfH3RI1o6NaJKnVplvoRMOwdDut5I0pp3H8213DGwaookPA==\" rel=\"nofollow\" target=\"_blank\">http:\/\/www.sec.gov<\/a>\u00a0or by contacting D. Boral Capital LLC, 590 Madison Avenue, 39th Floor New York, NY 10022. For more detailed description of the securities in this offering please refer to the Company\u2019s SEC filings at: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dM2sASF-_PWRpM4xq5FwBS8GPTHqNuD9pTV186bOHY1sZndVvaSPPWRAebdCVKSXj_rFvcnWSqsXRRV_fCBnHcOID9lqK3UNNVnDmxMUvIo6YWymNhCZPpRbA9Erm__dQWQYjvzVwkr4CQ-vp5vXgND26yrM3m3lTY8oAVjiMLUIVYm2G70HsZE4gyXVMhavlIG0A1MFHDzbDU52wGyuKXpXc-Psw6OfU7k-MiHXOu2vubWeAGS847RsQB1r625KX5eR_OTN7B6SS4IuvTrTS6ORZ3-hJXg-kNLpJiWl6FPz_FS6fgIqRAIWAccOrviAXQ_YiCz7ccaU5343gx4yye7YDa54xfhhizwRMIUdK3l9dWvCo6mW6L0AzkfbWohZ-2z9hu9UHHYF_VTMF3X3XugkTMedXcKTPiLqsQYfUMXsbUabFtbMGBQwphx-fLmYTcTg7NCO-PR9CpBAQwiD0gTVvpUx9DUtBOuh3Tzi1Sc=\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.sec.gov\/edgar\/search\/#\/ciks=0001986247&amp;entityName=Park%2520Ha%2520Biological%2520Technology%2520Co.%252C%2520Ltd.%2520(BYAH)%2520(CIK%25200001986247)<\/a><\/p>\n<p align=\"justify\">This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.<\/p>\n<p>\n        <b>About the Company<\/b>\n      <\/p>\n<p align=\"justify\">Established in 2016, Park Ha Biological Technology Co., Ltd. is primarily engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions under the proprietary brand \u201cPark Ha\u201d, with a commitment to providing cost-effective solutions to skin problems and improving the confidence of women in need of skin treatment. As of October 31, 2025, the Company has five directly operated stores and 22 franchisees in China. As part of its value-added service for the products, the Company offers \u201clight beauty experience\u201d, a quick complimentary after-sales beauty service performed in the directly operated stores and franchise stores. For more information, please visit the Company\u2019s website:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qgRIfJlEQRhOGMxJOvC6_1Z9TwjrvgYC_0gEX2T-GEz-W3IyVZs3A3y0ch1yUM8daQvjs192IRWPmKMU2jpe8AY9pehY2BKwFB1jIIj9Rnk=\" rel=\"nofollow\" target=\"_blank\">http:\/\/ir.parkha.cn\/<\/a>.<b>\u00a0<\/b><\/p>\n<p>\n        <b>Forward-Looking Statements<\/b>\n      <\/p>\n<p align=\"justify\">Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company\u2019s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. Investors can identify these forward-looking statements by words or phrases such as \u201cmay\u201d, \u201cwill\u201d, \u201cexpect\u201d, \u201canticipate\u201d, \u201caim\u201d, \u201cestimate\u201d, \u201cintend\u201d, \u201cplan\u201d, \u201cbelieve\u201d, \u201cis\/are likely to\u201d, \u201cpotential\u201d, \u201ccontinue\u201d or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company\u2019s registration statement and other filings with the SEC.<\/p>\n<p>\n        <b>For more information, please contact:<\/b>\n      <\/p>\n<p>\n        <b>D. Boral Capital LLC<\/b><br \/>\n        <br \/>590 Madison Avenue, 39th Floor<br \/>New York, NY 10022<br \/>Main Phone: +1 (212) 970-5150<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VIxAzC4vfNfkrJYGRF19EAx2Yt55IF-hyEbaR3g2IKiv6ZGdW-MEe923zKw2DvF97iOH2TeQ9j7M5t8odrkV9SJckoFmmzE5mqg-DgRZCYo=\" rel=\"nofollow\" target=\"_blank\">www.dboralcapital.com<\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=u_yFOlJwi4PuzX6QuB3gEk8BsxlM30QYXb57sjyOx2X95Tx89d595UPUgKSWmoVsx4vz9Ywo4ywYA-hked7Q1jqLiYqaJkzXYJvo2lpQKRYgfMAhNlpCJrKRPJ9BMMJ-UxReHuf9Hxk7-Th3r4x8jQ==\" rel=\"nofollow\" target=\"_blank\">dbccapitalmarkets@dboralcapital.com<\/a>\u00a0<\/p>\n<p>\n        <b>Park Ha Biological Technology Co., Ltd.<\/b><br \/>\n        <br \/>901 &amp; 901-2, Building C<br \/>Phase\u00a02, Wuxi International Life Science Innovation Campus<br \/>196 Jinghui East Road<br \/>Xinwu District, Wuxi, Jiangsu Province<br \/>People\u2019s Republic of China 214000<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qgRIfJlEQRhOGMxJOvC6_1Z9TwjrvgYC_0gEX2T-GEziphAN3S39GUGwJ1IOgU6RFQA5mtwdwQuPbRRkaGm_xuv4yKd-rZ_yMIZcxPFDRCE=\" rel=\"nofollow\" target=\"_blank\">http:\/\/ir.parkha.cn\/<\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-UJJUMmHpyXWJ6vH6W1TBFD3Z_XlP4IWMeEk_76GE-h0mQ9OugtbCnuKwPAnRcCb9SZZ0tSjECfSgmvqnRbGhAfYmqCnLW4_xNMuC7g46NQ=\" rel=\"nofollow\" target=\"_blank\">ir_parkha@163.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0NzE2MCM3NjYyMzE3IzUwMDE1Mzg0NA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MzQyYjNhZDktOTljNC00MjZkLWI3ZGUtMDRlMDZiMWIxNDRmLTUwMDE1Mzg0NC0yMDI2LTA2LTE1LWVu\/tiny\/Park-Ha-Biological-Technology-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Wuxi, China, June 15, 2026 (GLOBE NEWSWIRE) &#8212; Park Ha Biological Technology Co., Ltd., (NASDAQ: BYAH) an exempted company with limited liability incorporated under the laws of the Cayman Islands (the \u201cCompany\u201d), today announced the closing of its previously announced registered direct offering with several investors for the sale and purchase of an aggregate of up to 1,133,332 of the Company\u2019s Class A ordinary shares, par value $0.001 each (the \u201cClass A Ordinary Shares\u201d), and pre-funded warrants (the \u201cPre-Funded Warrants\u201d) to purchase up to 200,000 Class A Ordinary Shares, at a combined purchase price of $1.50 per Class A Ordinary Share and Pre-Funded Warrant. The gross proceeds to the Company from the registered direct offering are estimated to be approximately &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Park Ha Biological Technology Co., Ltd. Announces Closing of $2.0 Million Registered Direct Offering&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-972310","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Park Ha Biological Technology Co., Ltd. Announces Closing of $2.0 Million Registered Direct Offering - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Park Ha Biological Technology Co., Ltd. Announces Closing of $2.0 Million Registered Direct Offering - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Wuxi, China, June 15, 2026 (GLOBE NEWSWIRE) &#8212; Park Ha Biological Technology Co., Ltd., (NASDAQ: BYAH) an exempted company with limited liability incorporated under the laws of the Cayman Islands (the \u201cCompany\u201d), today announced the closing of its previously announced registered direct offering with several investors for the sale and purchase of an aggregate of up to 1,133,332 of the Company\u2019s Class A ordinary shares, par value $0.001 each (the \u201cClass A Ordinary Shares\u201d), and pre-funded warrants (the \u201cPre-Funded Warrants\u201d) to purchase up to 200,000 Class A Ordinary Shares, at a combined purchase price of $1.50 per Class A Ordinary Share and Pre-Funded Warrant. The gross proceeds to the Company from the registered direct offering are estimated to be approximately &hellip; Continue reading &quot;Park Ha Biological Technology Co., Ltd. Announces Closing of $2.0 Million Registered Direct Offering&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-15T20:34:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0NzE2MCM3NjYyMzE3IzUwMDE1Mzg0NA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Park Ha Biological Technology Co., Ltd. Announces Closing of $2.0 Million Registered Direct Offering\",\"datePublished\":\"2026-06-15T20:34:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\\\/\"},\"wordCount\":765,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc0NzE2MCM3NjYyMzE3IzUwMDE1Mzg0NA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\\\/\",\"name\":\"Park Ha Biological Technology Co., Ltd. Announces Closing of $2.0 Million Registered Direct Offering - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc0NzE2MCM3NjYyMzE3IzUwMDE1Mzg0NA==\",\"datePublished\":\"2026-06-15T20:34:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc0NzE2MCM3NjYyMzE3IzUwMDE1Mzg0NA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc0NzE2MCM3NjYyMzE3IzUwMDE1Mzg0NA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Park Ha Biological Technology Co., Ltd. Announces Closing of $2.0 Million Registered Direct Offering\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Park Ha Biological Technology Co., Ltd. Announces Closing of $2.0 Million Registered Direct Offering - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\/","og_locale":"en_US","og_type":"article","og_title":"Park Ha Biological Technology Co., Ltd. Announces Closing of $2.0 Million Registered Direct Offering - Market Newsdesk","og_description":"Wuxi, China, June 15, 2026 (GLOBE NEWSWIRE) &#8212; Park Ha Biological Technology Co., Ltd., (NASDAQ: BYAH) an exempted company with limited liability incorporated under the laws of the Cayman Islands (the \u201cCompany\u201d), today announced the closing of its previously announced registered direct offering with several investors for the sale and purchase of an aggregate of up to 1,133,332 of the Company\u2019s Class A ordinary shares, par value $0.001 each (the \u201cClass A Ordinary Shares\u201d), and pre-funded warrants (the \u201cPre-Funded Warrants\u201d) to purchase up to 200,000 Class A Ordinary Shares, at a combined purchase price of $1.50 per Class A Ordinary Share and Pre-Funded Warrant. The gross proceeds to the Company from the registered direct offering are estimated to be approximately &hellip; Continue reading \"Park Ha Biological Technology Co., Ltd. Announces Closing of $2.0 Million Registered Direct Offering\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-15T20:34:45+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0NzE2MCM3NjYyMzE3IzUwMDE1Mzg0NA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Park Ha Biological Technology Co., Ltd. Announces Closing of $2.0 Million Registered Direct Offering","datePublished":"2026-06-15T20:34:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\/"},"wordCount":765,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0NzE2MCM3NjYyMzE3IzUwMDE1Mzg0NA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\/","name":"Park Ha Biological Technology Co., Ltd. Announces Closing of $2.0 Million Registered Direct Offering - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0NzE2MCM3NjYyMzE3IzUwMDE1Mzg0NA==","datePublished":"2026-06-15T20:34:45+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0NzE2MCM3NjYyMzE3IzUwMDE1Mzg0NA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0NzE2MCM3NjYyMzE3IzUwMDE1Mzg0NA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/park-ha-biological-technology-co-ltd-announces-closing-of-2-0-million-registered-direct-offering\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Park Ha Biological Technology Co., Ltd. Announces Closing of $2.0 Million Registered Direct Offering"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/972310","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=972310"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/972310\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=972310"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=972310"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=972310"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}